Pharma news
Americas
The Bay Area of California has one
of the greatest concentrations of life
sciences companies in the world,
but its biotech community is being
threatened by the seemingly
unstoppable rise of large technology businesses. LSIPR spoke to Christopher Stewart, chair, and Robert Eyler,
vice chair, of the new North Bay
Life Science Alliance to find out
how it plans to strengthen the network in the area. 30 September 2014
Pharma
Increasing numbers of patent challengers are finding the USPTO’s post-grant procedures to be attractive alternatives to district court litigation, write Arlene Chow and Peter Noh. 29 September 2014
Americas
A trade deal between the EU and Canada, due to be signed today if last-minute German concerns can be overcome, would have implications for pharmaceutical IP protection and could raise the cost of drugs in Canada, a report has claimed. 26 September 2014
Asia
Law firm Miller, Canfield, Paddock & Stone has expanded its IP team in China with the appointment of life sciences specialist Kening Li. 24 September 2014
Americas
Generic drug maker Par Pharmaceutical Companies has settled a long running dispute with Salix Pharmaceuticals over its heartburn drug Zegerid (omeprazole/sodium bicarbonate). 23 September 2014
Pharma
A newly revealed malware could be looking to attack the pharmaceutical sector in order to steal IP, a report has claimed. 15 September 2014
Americas
Law firm Kilpatrick Townsend & Stockton LLP has bolstered its Californian team with the appointment of a new pharmaceutical IP specialist. 12 September 2014
Pharma
UK-based law firm Carpmaels & Ransford LLP has announced the appointment of two new partners to its London office. 11 September 2014
Americas
Bristol-Myers Squibb has accused pharmaceutical company Merck of infringing a patent covering a method used to treat cancer. 10 September 2014
Americas
Sifting through the published comments on the USPTO’s Myriad/Mayo guidelines, LSIPR found them to be overwhelmingly negative. 4 September 2014